United States
Vioxx (Rofecoxib)
Banned in 2004
Increased risk of heart attack and stroke
Bextra (Valdecoxib)
Banned in 2005
Cardiovascular risks and severe skin reactions
Darvon & Darvocet (Propoxyphene)
Banned in 2010
Heart rhythm abnormalities
Phenylpropanolamine
Banned in 2001
Risk of stroke
Sibutramine
Banned in 2010
Cardiovascular risks
United Kingdom
Thalidomide
Banned in 1961
Severe birth defects
Seroxat (Paroxetine) for under-18s
Banned in 2003
Increased risk of suicidal behavior in young people
Rofecoxib (Vioxx)
Banned in 2004
Increased cardiovascular risks
Dextropropoxyphene
Banned in 2010
Risk of heart rhythm problems
Sibutramine
Banned in 2011
Cardiovascular risks
Canada
Phenylpropanolamine
Banned in 2001
Risk of stroke
Sibutramine
Banned in 2010
Increased risk of heart attack and stroke
Rofecoxib (Vioxx)
Banned in 2004
Increased cardiovascular risks
Clozapine
Banned in 1998
Risk of severe agranulocytosis
Tegaserod
Banned in 2007
Increased risk of heart attack and stroke
Australia
Sibutramine
Banned in 2010
Increased cardiovascular risk
Rofecoxib (Vioxx)
Banned in 2005
Increased risk of heart attack and stroke
Clozapine
Banned in 1998
Severe side effects including agranulocytosis
Phenylpropanolamine
Banned in 2001
Risk of stroke
Dextropropoxyphene
Banned in 2010
Risk of heart rhythm problems
India
Rofecoxib
Banned in 2004
Increased risk of heart attacks
Sibutramine
Banned in 2010
Weight loss drug with cardiovascular risks
Phenylpropanolamine
Banned in 2001
Risk of hemorrhagic stroke
Methylphenidate (Ritalin)
Restricted in 2018
Potential for abuse and addiction
Dextropropoxyphene
Banned in 2010
Risk of heart rhythm problems
Germany
Rofecoxib (Vioxx)
Banned in 2005
Increased cardiovascular risks
Sibutramine
Banned in 2010
Serious cardiovascular side effects
Clozapine
Banned for certain uses
Risk of severe blood disorders
Nimesulide
Banned in 2012
Risk of liver toxicity
Dexfenfluramine
Banned in 2000
Associated with pulmonary hypertension
France
Mediator (Benfluorex)
Banned in 2009
Severe cardiovascular effects
Rofecoxib
Banned in 2004
Increased risk of heart attack
Sibutramine
Banned in 2012
Cardiovascular risks
Thalidomide
Banned in 1961
Severe birth defects
Dextropropoxyphene
Banned in 2010
Risk of heart problems
Japan
Thalidomide
Banned in 1962
Causes severe birth defects
Sibutramine
Banned in 2010
Cardiovascular risks
Rofecoxib
Banned in 2004
Increased cardiovascular risks
Phenylpropanolamine
Banned in 2001
Risk of stroke
Dexfenfluramine
Banned in 2000
Pulmonary hypertension risks